Work

Editorial: Proteostasis in cardiac health and disease

Year: 2024
Type: editorial
Abstract: However, the detailed insights provided in this review and the results of a recent study by Wu et al. give rise to the possibility of USP-13 involvement in cardiac diseases (8). Recent evidence suggests that the cytoskeleton of cardiomyocytes is crucial for maintaining balanced communica�on between the various components of the proteostasis network (2). One of the cri�cal components of the cytoskeleton is the intermediate filament protein, desmin. Gene�c varia�ons and loss of desmin cause desminopathies, including desmin-related cardiomyopathies. The review by Su et al. discusses the role of desmin impairment as a trigger for cardiac arrythmias and the underlying molecular mechanisms. A derailment of PQC with the forma�on of aberrant protein aggregates can have dras�c effects in cardiac diseases (1,2). Petersen et al. discovered Fibin, fin bud ini�a�on factor homolog, as a novel protein induced in cardiac hypertrophy. In vitro, using neonatal rat ventricular cardiomyocytes, they found Fibin to act as a regulator of cardiomyocyte hypertrophy through inhibi�on of SRF and NFAT signaling, two well described pathways involved in cardiomyocyte hypertrophy. In the expecta�on of a posi�ve effect on cardiac hypertrophy, they next inves�gated the role of Fibin in vivo, using a cardiomyocyte restricted Fibin overexpression mouse model. Surprisingly however, these transgenic mice developed dilated cardiomyopathy and cardiac dysfunc�on in aging, pressure-overload, and calcineurin mouse models. The cause of this unexpected phenotype was iden�fied as the result of a proteostasis perturba�on leading to aberrant protein aggrega�on, increased ER stress and the Uncoupled Protein Response (UPR), resul�ng in UPR-mediated apoptosis. Thus, this study demonstrates the importance of balanced proteostasis and exemplifies the poten�ally devasta�ng effects of dysregulated proteostasis on the heart. Overall, these studies demonstrate the importance and complexity of cardiac proteostasis. While research into cardiac proteostasis is s�ll in its infancy, protein homeostasis has been implicated in the context of aging. As we age, proteoly�c ac�vity declines resul�ng in the accumula�on of damaged proteins and aggregates, which are causal in the onset of several chronic diseases (9). Best characterized are the effects of toxic accumula�ons in the age-related neurodegenera�ve diseases, Parkinson's, Alzheimer's, and Hun�ngton's Disease (10). However, more and more evidence suggest that a decline in PQC may be causal for the development of other widespread diseases, including obesity and type 2 diabetes (9)(10)(11). The health burden caused by the aforemen�oned diseases requires mul�disciplinary studies to elucidate a possible link between the derailment of proteostasis in different diseases. One intriguing possibility is the idea of trea�ng mul�ple diseases by therapeu�cally improving proteasome func�on (3). One poten�al, rela�vely recent approach is the ac�va�on of the proteasome by small molecules (12). Even though several promising possible targets and compounds are emerging, the consequences and side effects of chronic exposure to proteasome enhancers are not yet known. However, in the future, therapeu�cally targe�ng proteostasis could open completely new possibili�es in the treatment of widespread diseases, including CVDs.
Language: English
Open Access status: gold
Estimated APC paid: $3,295
OpenAlex ID: W4399240144
Cites: 12
Cited by: 8
Related to: 10